{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:25:03Z","timestamp":1783394703250,"version":"3.54.6"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Deutsche Diabetes Gesellschaft (DDG)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.reprotox.2018.07.004","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T13:17:47Z","timestamp":1531315067000},"page":"79-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Pregnancy outcome after first-trimester exposure to metformin: A prospective cohort study"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2811-5040","authenticated-orcid":false,"given":"Stephan","family":"Scherneck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Schlinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelin","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Grupe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Weber-Schoendorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. (1)","key":"10.1016\/j.reprotox.2018.07.004_bib0005","article-title":"Standards of medical care in diabetes\u20142017","volume":"40","author":"A.D. Association","year":"2017","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.reprotox.2018.07.004_bib0010","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1210\/jc.2013-2465","article-title":"Diabetes and pregnancy: an endocrine society clinical practice guideline","volume":"98","author":"Blumer","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.reprotox.2018.07.004_bib0015","series-title":"Excellence, Diabetes in Pregnancy: Management from Preconception to the Postnatal Period","author":"N.I.f.H.a.C","year":"2015"},{"key":"10.1016\/j.reprotox.2018.07.004_bib0020","series-title":"Diabetes und Schwangerschaft - Evidenzbasierte Leitlinie der Deutschen Diabetes-Gesellschaft","author":"Kleinwechter","year":"2014"},{"issue":"7","key":"10.1016\/j.reprotox.2018.07.004_bib0025","doi-asserted-by":"crossref","DOI":"10.5694\/j.1326-5377.2005.tb07087.x","article-title":"The Australasian diabetes in pregnancy society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy","volume":"183","author":"McElduff","year":"2005","journal-title":"Med. J. Aust."},{"issue":"11","key":"10.1016\/j.reprotox.2018.07.004_bib0030","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2337\/diacare.18.11.1446","article-title":"Congenital malformations in pregnancies complicated by NIDDM","volume":"18","author":"Towner","year":"1995","journal-title":"Diabetes Care"},{"issue":"19","key":"10.1016\/j.reprotox.2018.07.004_bib0035","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","article-title":"Metformin versus insulin for the treatment of gestational diabetes","volume":"358","author":"Rowan","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.reprotox.2018.07.004_bib0040","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/humrep\/17.8.1950","article-title":"Should patients with polycystic ovarian syndrome be treated with metformin? An enthusiastic endorsement","volume":"17","author":"Nestler","year":"2002","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.reprotox.2018.07.004_bib0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0015-0282(00)01666-6","article-title":"Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study","volume":"75","author":"Glueck","year":"2001","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.reprotox.2018.07.004_bib0050","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jcem.87.2.8207","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.reprotox.2018.07.004_bib0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJM199801153380302","article-title":"Prepregnancy weight and the risk of adverse pregnancy outcomes","volume":"338","author":"Cnattingius","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.reprotox.2018.07.004_bib0060","doi-asserted-by":"crossref","first-page":"j2563","DOI":"10.1136\/bmj.j2563","article-title":"Risk of major congenital malformations in relation to maternal overweight and obesity severity: cohort study of 1.2 million singletons","volume":"357","author":"Persson","year":"2017","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.reprotox.2018.07.004_bib0065","first-page":"778","article-title":"Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial, the lancet","volume":"3","author":"Chiswick","year":"2015","journal-title":"Diabetes Endocrinol."},{"issue":"5","key":"10.1016\/j.reprotox.2018.07.004_bib0070","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1509819","article-title":"Metformin versus placebo in obese pregnant women without diabetes mellitus","volume":"374","author":"Syngelaki","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.reprotox.2018.07.004_bib0075","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/bcp.12672","article-title":"Metformin versus insulin for gestational diabetes mellitus: a meta-analysis","volume":"80","author":"Zhao","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.reprotox.2018.07.004_bib0080","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/humupd\/dmu022","article-title":"First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis","volume":"20","author":"Cassina","year":"2014","journal-title":"Hum. Reprod. Update"},{"issue":"39","key":"10.1016\/j.reprotox.2018.07.004_bib0085","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bcp.13481","article-title":"Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services","volume":"84","author":"Panchaud","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.reprotox.2018.07.004_bib0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.reprotox.2008.06.006","article-title":"Statistical methods for estimating the probability of spontaneous abortion in observational studies\u2013analyzing pregnancies exposed to coumarin derivatives","volume":"26","author":"Meister","year":"2008","journal-title":"Reprod. Toxicol."},{"issue":"9596","key":"10.1016\/j.reprotox.2018.07.004_bib0095","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.reprotox.2018.07.004_bib0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10072-006-0675-y","article-title":"Epilepsy and polycystic ovary syndrome: where is the link?","volume":"27","author":"Bilo","year":"2006","journal-title":"Neurol. Sci."},{"issue":"19","key":"10.1016\/j.reprotox.2018.07.004_bib0105","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM199311043291904","article-title":"Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy","volume":"329","author":"Isojarvi","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.reprotox.2018.07.004_bib0110","series-title":"Physical Status: the Use and Interpretation of Anthropometry. Report of a WHO Expert Committee","first-page":"1","author":"WHO","year":"1995"},{"key":"10.1016\/j.reprotox.2018.07.004_bib0115","series-title":"(EUROCAT), Complete EUROCAT Guide 1.4 and Reference Documents (Version 08.09.17)","author":"E.S.o.C.A","year":"2016"},{"issue":"19","key":"10.1016\/j.reprotox.2018.07.004_bib0120","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D\u2019Agostino","year":"1998","journal-title":"Stat. Med."},{"issue":"4","key":"10.1016\/j.reprotox.2018.07.004_bib0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1037\/1082-989X.9.4.403","article-title":"Propensity score estimation with boosted regression for evaluating causal effects in observational studies","volume":"9","author":"McCaffrey","year":"2004","journal-title":"Psychol. Methods"},{"issue":"10","key":"10.1016\/j.reprotox.2018.07.004_bib0130","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1055\/s-2006-924458","article-title":"Analyse des Neugeborenenkollektivs der Bundesrepublik Deutschland","volume":"66","author":"Voigt","year":"2006","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"1","key":"10.1016\/j.reprotox.2018.07.004_bib0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1055\/s-0029-1241833","article-title":"Short communication about percentile values of body measures of newborn babies","volume":"214","author":"Voigt","year":"2010","journal-title":"Z Geburtshilfe Neonatol"},{"key":"10.1016\/j.reprotox.2018.07.004_bib0140","series-title":"Statistical Analysis With Missing Data","author":"Little","year":"2002"},{"key":"10.1016\/j.reprotox.2018.07.004_bib0145","series-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"2004"},{"issue":"4","key":"10.1016\/j.reprotox.2018.07.004_bib0150","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/pds.3744","article-title":"Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome","volume":"24","author":"Wacker","year":"2015","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"8","key":"10.1016\/j.reprotox.2018.07.004_bib0155","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/adc.2005.071761","article-title":"Principles of evidence based medicine","volume":"90","author":"Akobeng","year":"2005","journal-title":"Arch. Dis. Child."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623818301497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623818301497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:49:22Z","timestamp":1760190562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623818301497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":31,"alternative-id":["S0890623818301497"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2018.07.004","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy outcome after first-trimester exposure to metformin: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2018.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}